Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Business Off The Beaten Path: Theresa Deisher, PhD, Research and Development Dir, AVM Biotechnology

  • Broadcast in Business
Mary Anne Dorward

Mary Anne Dorward


Follow This Show

If you liked this show, you should follow Mary Anne Dorward.
Guest: Theresa Deisher, PhD, Research and Development Director, AVM Biotechnology. Join us as we discuss the latest in fetal stem cell research. Learn the important difference in the safety and efficacy of adult and cord blood stem cells, versus embryonic and aborted fetal stem cells. Dr Deisher is working to provide safe, effective and affordable alternative vaccines and stem cell therapies that are not tainted by embryonic or electively aborted fetal materials. We will also discuss the true medical benefits from economical stem cell research that is also respectful to human life and taxpayer dollars. Reach Dr Deisher and AVM at www.avmbiotech.com